Literature DB >> 2429320

Two proto-oncogenes implicated in mammary carcinogenesis, int-1 and int-2, are independently regulated during mouse development.

A Jakobovits, G M Shackleford, H E Varmus, G R Martin.   

Abstract

The int-1 and int-2 genes were first isolated as targets for transcriptional activation by proviral insertion mutations in mammary carcinomas induced by the mouse mammary tumor virus (MMTV). Since these proto-oncogenes are not expressed at detectable levels in previously tested normal tissues from adult mice, we sought to determine whether these genes might be active during embryogenesis by examining mouse embryos and cultured teratocarcinoma cells for RNA encoded by int-1 and int-2. A single size class of int-1 RNA is present only at mid-gestation stages of development (days 8 through 13) and is also detected in testes from postpuberal mice. Four species of int-2 RNA are found in peri-implantation embryos and teratocarcinoma cells and are particularly abundant in derivatives of the primitive endodermal lineage, but int-2 RNA is not detected during mid- or late gestation or in any normal adult tissues tested. Thus, these two proto-oncogenes, activated during mammary carcinogenesis by the same mechanisms, are normally expressed at different times and places in embryonic and adult mice.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2429320      PMCID: PMC386811          DOI: 10.1073/pnas.83.20.7806

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Neoplastic differentiation: characteristics of cell lines derived from a murine teratocarcinoma.

Authors:  J M Lehman; W C Speers; D E Swartzendruber; G B Pierce
Journal:  J Cell Physiol       Date:  1974-08       Impact factor: 6.384

2.  Differential expression of cellular oncogenes during pre- and postnatal development of the mouse.

Authors:  R Müller; D J Slamon; J M Tremblay; M J Cline; I M Verma
Journal:  Nature       Date:  1982-10-14       Impact factor: 49.962

3.  Number and evolutionary conservation of alpha- and beta-tubulin and cytoplasmic beta- and gamma-actin genes using specific cloned cDNA probes.

Authors:  D W Cleveland; M A Lopata; R J MacDonald; N J Cowan; W J Rutter; M W Kirschner
Journal:  Cell       Date:  1980-05       Impact factor: 41.582

4.  The development of cystic embryoid bodies in vitro from clonal teratocarcinoma stem cells.

Authors:  G R Martin; L M Wiley; I Damjanov
Journal:  Dev Biol       Date:  1977-12       Impact factor: 3.582

5.  Nucleotide sequence and expression in vitro of cDNA derived from mRNA of int-1, a provirally activated mouse mammary oncogene.

Authors:  Y K Fung; G M Shackleford; A M Brown; G S Sanders; H E Varmus
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

6.  Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome.

Authors:  R Nusse; H E Varmus
Journal:  Cell       Date:  1982-11       Impact factor: 41.582

Review 7.  Teratocarcinomas and mammalian embryogenesis.

Authors:  G R Martin
Journal:  Science       Date:  1980-08-15       Impact factor: 47.728

8.  Hormonal induction of differentiation in teratocarcinoma stem cells: generation of parietal endoderm by retinoic acid and dibutyryl cAMP.

Authors:  S Strickland; K K Smith; K R Marotti
Journal:  Cell       Date:  1980-09       Impact factor: 41.582

9.  Tunicamycin reversibly inhibits the terminal differentiation of teratocarcinoma stem cells to endoderm.

Authors:  L B Grabel; G R Martin
Journal:  Dev Biol       Date:  1983-01       Impact factor: 3.582

10.  Tumorigenesis by mouse mammary tumor virus: evidence for a common region for provirus integration in mammary tumors.

Authors:  G Peters; S Brookes; R Smith; C Dickson
Journal:  Cell       Date:  1983-06       Impact factor: 41.582

View more
  57 in total

1.  GATA-4 interacts distinctively with negative and positive regulatory elements in the Fgf-3 promoter.

Authors:  Akira Murakami; Sanami Ishida; Clive Dickson
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

Review 2.  Experimental approaches to nutrition and cancer: fats, calories, vitamins and minerals.

Authors:  R A Good; E Lorenz; R Engelman; N K Day
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

3.  Introduction of a lacZ reporter gene into the mouse int-2 locus by homologous recombination.

Authors:  S L Mansour; K R Thomas; C X Deng; M R Capecchi
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

4.  The Wnt-1 (int-1) oncogene promoter and its mechanism of activation by insertion of proviral DNA of the mouse mammary tumor virus.

Authors:  R Nusse; H Theunissen; E Wagenaar; F Rijsewijk; A Gennissen; A Otte; E Schuuring; A van Ooyen
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

5.  NoBP, a nuclear fibroblast growth factor 3 binding protein, is cell cycle regulated and promotes cell growth.

Authors:  K Reimers; M Antoine; M Zapatka; V Blecken; C Dickson; P Kiefer
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

6.  A distinctive family of embryonic protein-tyrosine kinase receptors.

Authors:  E B Pasquale
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

7.  Inducible expression of FGF-3 in mouse mammary gland.

Authors:  Elly S W Ngan; Zhi-Qing Ma; Steven S Chua; Francesco J DeMayo; Sophia Y Tsai
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-08       Impact factor: 11.205

8.  Expression of the int-1 and int-2 loci in endogenous mouse mammary tumor virus-induced mammary tumorigenesis in the C3Hf mouse.

Authors:  P R Etkind
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

9.  Binary system for regulating transgene expression in mice: targeting int-2 gene expression with yeast GAL4/UAS control elements.

Authors:  D M Ornitz; R W Moreadith; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

Review 10.  Genetic alterations in primary breast cancer.

Authors:  R Callahan
Journal:  Breast Cancer Res Treat       Date:  1989-07       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.